Physician

Yuk-Yuen Max Leung, M.D.

According to 2025 Medicare claims, Yuk-Yuen Leung, M.D. (NPI: 1083612949) practices urology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is UROLOGY ASSOCIATES OF CENTRAL CALIFORNIA MEDICAL GROUP INC (NPI: 1194720722; TIN: 770361443) and primary practice location at 93720-0155.

Leung's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,446 traditional Medicare patients, billed 43,808 HCPCS/CPT codes, and received $1,166,537 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,613 prescription claims across 916 beneficiaries totaling $1,365,219 in drug costs, led by Xtandi (Enzalutamide). DME data shows 86 claims. Open Payments data shows 66 records totaling $33,657. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $404,374 and ending at $1,365,219. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $742 to $335.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,359	78,599	$895,184
2016	1,545	79,040	$862,645
2017	1,645	76,900	$923,966
2018	1,676	86,342	$1,146,753
2019	1,689	64,087	$1,130,337
2020	1,551	54,636	$1,198,108
2021	1,531	58,150	$983,352
2022	1,562	51,354	$1,104,244
2023	1,515	48,578	$979,537
2024	1,446	43,808	$1,166,537

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	700	3,653	$404,374
2016	840	4,404	$758,769
2017	831	4,036	$921,329
2018	799	3,588	$1,136,013
2019	811	3,582	$1,042,344
2020	778	3,501	$1,224,574
2021	823	3,617	$818,187
2022	848	3,485	$523,611
2023	882	3,449	$1,013,158
2024	916	3,613	$1,365,219

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	64	$1,278
2016	N/R	83	$2,154
2017	N/R	126	$22,885
2018	12	94	$13,801
2019	18	126	$38,250
2020	16	79	$32,450
2021	17	92	$32,860
2022	21	136	$41,922
2023	20	132	$45,031
2024	21	86	$30,348

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	586	788	$101
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	742	918	$68
51798	Ultrasound measurement of bladder capacity after voiding	603	768	$9
36415	Insertion of needle into vein for collection of blood sample	497	571	$8
81001	Manual urinalysis test with examination using microscope, automated	525	617	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	74	2,220	$986,085
Myrbetriq	Mirabegron	131	6,224	$92,692
Gemtesa	Vibegron	29	1,410	$22,919
Premarin	Estrogens, Conjugated	43	3,011	$18,535
Tamsulosin Hcl	Tamsulosin Hcl	888	70,109	$15,605

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	21	75	$27,841
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	11	$2,506

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	66	$33,657	INTUITIVE SURGICAL, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yuk-Yuen Max Leung, M.D.?

Tedicare shows public-source Medicare data for Yuk-Yuen Max Leung, M.D. (NPI 1083612949), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yuk-Yuen Max Leung, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yuk-Yuen Max Leung, M.D.?

Yuk-Yuen Max Leung, M.D. is linked to UROLOGY ASSOCIATES OF CENTRAL CALIFORNIA MEDICAL GROUP INC (billing NPI 1194720722) in the available physician profile data.

Does Yuk-Yuen Max Leung, M.D. have Open Payments data?

Yuk-Yuen Max Leung, M.D. has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.